Hiroshi Yatsuhashi

10.4k total citations
185 papers, 4.4k citations indexed

About

Hiroshi Yatsuhashi is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Hiroshi Yatsuhashi has authored 185 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Hepatology, 127 papers in Epidemiology and 26 papers in Rheumatology. Recurrent topics in Hiroshi Yatsuhashi's work include Liver Disease Diagnosis and Treatment (107 papers), Hepatitis C virus research (94 papers) and Hepatitis B Virus Studies (75 papers). Hiroshi Yatsuhashi is often cited by papers focused on Liver Disease Diagnosis and Treatment (107 papers), Hepatitis C virus research (94 papers) and Hepatitis B Virus Studies (75 papers). Hiroshi Yatsuhashi collaborates with scholars based in Japan, United States and United Kingdom. Hiroshi Yatsuhashi's co-authors include Hiromi Ishibashi, Kiyoshi Migita, Atsumasa Komori, Michitami Yano, Minoru Nakamura, Seigo Abiru, Michiaki Koga, Manabu Daikoku, Katsumi Eguchi and Koji Yano and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer.

In The Last Decade

Hiroshi Yatsuhashi

177 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Yatsuhashi Japan 38 3.0k 2.9k 506 500 477 185 4.4k
Maria Lorena Abate Italy 31 3.1k 1.1× 3.2k 1.1× 688 1.4× 302 0.6× 520 1.1× 99 4.8k
Zu‐Yau Lin Taiwan 37 3.0k 1.0× 2.8k 1.0× 538 1.1× 351 0.7× 241 0.5× 205 4.3k
Hidenori Ochi Japan 36 2.3k 0.8× 2.7k 0.9× 734 1.5× 358 0.7× 237 0.5× 119 4.1k
Kaname Yoshizawa Japan 33 3.0k 1.0× 3.2k 1.1× 391 0.8× 1.1k 2.1× 1.1k 2.3× 124 4.7k
Takeji Umemura Japan 36 2.5k 0.8× 3.0k 1.0× 483 1.0× 1.2k 2.4× 840 1.8× 223 4.8k
Luis A. Balart United States 23 2.9k 1.0× 2.7k 0.9× 365 0.7× 448 0.9× 489 1.0× 64 4.0k
Jerome S. Wollman United States 15 2.5k 0.9× 2.6k 0.9× 326 0.6× 493 1.0× 342 0.7× 17 4.4k
Kojiro Michitaka Japan 36 3.0k 1.0× 2.6k 0.9× 301 0.6× 688 1.4× 174 0.4× 207 4.5k
Jane Collier United Kingdom 32 2.2k 0.8× 2.4k 0.8× 632 1.2× 930 1.9× 312 0.7× 91 4.3k
Hans‐Peter Dienes Germany 31 2.3k 0.8× 2.2k 0.8× 795 1.6× 753 1.5× 368 0.8× 57 4.0k

Countries citing papers authored by Hiroshi Yatsuhashi

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Yatsuhashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Yatsuhashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Yatsuhashi more than expected).

Fields of papers citing papers by Hiroshi Yatsuhashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Yatsuhashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Yatsuhashi. The network helps show where Hiroshi Yatsuhashi may publish in the future.

Co-authorship network of co-authors of Hiroshi Yatsuhashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Yatsuhashi. A scholar is included among the top collaborators of Hiroshi Yatsuhashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Yatsuhashi. Hiroshi Yatsuhashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamana, Hayato, Kazumi Yamasaki, Taisuke Jo, Hiroshi Yatsuhashi, & Hideo Yasunaga. (2023). A descriptive analysis of acute viral hepatitis using a database with electronic medical records and claims data. PubMed. 5(4). 107–112. 2 indexed citations
2.
Fung, Scott, Calvin Q. Pan, Grace Lai–Hung Wong, et al.. (2023). Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary Pharmacology & Therapeutics. 59(2). 217–229. 7 indexed citations
3.
Kawado, Miyuki, Makiko Mieno, Shuji Hashimoto, et al.. (2023). HIV RNA and HCV RNA Levels, and Mortality: The Japan Cohort Study of HIV Patients Infected through Blood Products. The Open AIDS Journal. 17(1).
4.
Sugimori, Hiroki, Maki Hirao, Ataru Igarashi, et al.. (2022). Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan. Scientific Reports. 12(1). 17139–17139. 2 indexed citations
5.
Higuchi, Takashi, Shomi Oka, Hiroshi Furukawa, et al.. (2021). Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response. Human Genomics. 15(1). 6–6. 22 indexed citations
6.
Honda, Ryoko, Hiroshi Baba, Kohei Adachi, et al.. (2021). Developmental outcome after corpus callosotomy for infants and young children with drug-resistant epilepsy. Epilepsy & Behavior. 117. 107799–107799. 8 indexed citations
7.
Takehara, Tetsuo, Kazuaki Chayama, Masayuki Kurosaki, et al.. (2020). JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study. Journal of Gastroenterology. 55(6). 640–652. 3 indexed citations
8.
Imai, Shinobu, Hayato Yamana, Manabu Akazawa, et al.. (2019). Validity of administrative database detection of previously resolved hepatitis B virus in Japan. Journal of Medical Virology. 91(11). 1944–1948. 8 indexed citations
9.
Inamine, Tatsuo, et al.. (2013). Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients. Journal of Gastroenterology. 48(10). 1160–1170. 21 indexed citations
10.
Watanabe, Tsunamasa, Fuminaka Sugauchi, Yasuhito Tanaka, et al.. (2012). Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of theIL28Bgene. Gut. 62(9). 1340–1346. 18 indexed citations
11.
Yotsuyanagi, Hiroshi, Yasuhito Tanaka, Akihiko Saitoh, et al.. (2012). Universal vaccination of hepatitis B virus vaccine. Kanzo. 53(2). 117–130. 2 indexed citations
12.
Miyaaki, Hisamitsu, et al.. (2011). 1332 SUPPRESSOR OF CYTOKINE SIGNAL 3 AND IL28 GENETIC VARIATION PREDICT VALUE OF VIRAL RESPONSE TO PEGINTERFERON AND RIBAVIRIN. Journal of Hepatology. 54. S525–S526. 1 indexed citations
13.
Yatsuhashi, Hiroshi, et al.. (2008). Prevalence of Hepatitis C Virus and its genotypes among a cohort of drug users in Kenya. East African Medical Journal. 85(7). 318–25. 27 indexed citations
14.
Ozawa, Eisuke, Manabu Daikoku, Takeshi Sakai, et al.. (2008). Three cases of adult T-cell leukemia presented as acute liver failure with mutually different etiologies. Kanzo. 49(5). 209–217. 2 indexed citations
15.
Yano, Koji, et al.. (2007). . Kanzo. 48(3). 109–111. 2 indexed citations
16.
17.
Ito, Masahiro, et al.. (2006). Efficacy of the Liver US Score in Discriminating Early Stage Cirrhosis (F4) from Advanced Stage Chronic Hepatitis (F3). Choonpa Igaku. 33(6). 655–663. 2 indexed citations
18.
Wang, Aiping, Kiyoshi Migita, Masahiro Ito, et al.. (2005). Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. Journal of Autoimmunity. 25(1). 85–91. 70 indexed citations
19.
Yatsuhashi, Hiroshi, et al.. (1994). A case of domestically infected acute sporadic hepatitis E demonstratedby enzyme-linked immunoadsorbent assay (ELISA).. Kanzo. 35(7). 560–565. 2 indexed citations
20.
Yamaguchi, Naoyuki, et al.. (1991). A CASE REPORT OF MALIGNANT LYMPHOMA WITH HEPATOCELLULAR CARCINOMA. Acta gastro-enterologica belgica. 33(5).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Lorena Abate Breakdown of academic impact, for papers by Zu‐Yau Lin Breakdown of academic impact, for papers by Hidenori Ochi Breakdown of academic impact, for papers by Kaname Yoshizawa Breakdown of academic impact, for papers by Takeji Umemura Breakdown of academic impact, for papers by Luis A. Balart Breakdown of academic impact, for papers by Jerome S. Wollman Breakdown of academic impact, for papers by Kojiro Michitaka Breakdown of academic impact, for papers by Jane Collier Breakdown of academic impact, for papers by Hans‐Peter Dienes
Rankless by CCL
2026